当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Deacon RMJ
At present, learning and memory tests are widely used in the preclinical search for treatments for Alzheimer’s disease (AD). However, in most cases these tests do not probe “episodic memory” which is the type most affected in AD. This article describes a different approach to preclinical testing - the use of species-typical tasks. These mirror “activities of daily living,” impairments of which are noticeable in the earliest stages of the illness. These impairments are frequently more of a problem to the patient than the loss of cognitive abilities, and lead to a need for carers or institutionalisation, both of which can be costly. Species-typical tasks do not require food deprivation or aversive stimulation to motivate the animals; they are performed spontaneously. Moreover they are simple and cheap to execute. Thus they model an aspect of the disease more closely, are cost-effective, simpler and ethically sounder than current practices.